Related Experiment Video
Updated: Nov 29, 2025

Author Spotlight: Understanding Retinal Vessel Resilience and Disease Progression
Published on: January 12, 2024
Diabetic neuropathy in children and youth: New and emerging risk factors
Gulcin Akinci1, Masha G Savelieff1, Gary Gallagher1
1Department of Neurology, University of Michigan Medicine, Ann Arbor, Michigan, USA.
Insights
Diabetic neuropathy is increasing in children due to type 1 and type 2 diabetes, alongside obesity. More research is needed for prevention and management strategies in youth.
Area of Science:
- Pediatric Endocrinology
- Metabolic Disorders
- Neurology
Background:
- Diabetic neuropathy is a known complication in youth with type 1 diabetes.
- Rising rates of obesity and type 2 diabetes are expected to increase pediatric neuropathy incidence.
- Pathogenic insights and management strategies for pediatric diabetes-related neuropathy remain limited.
Purpose of the Study:
- To review the current knowledge on neuropathy in children and youth with type 1 and type 2 diabetes.
- To emphasize prevalence, clinical presentation, diagnostic approaches, and risk factors.
- To highlight current management strategies and recommendations.
Main Methods:
- Literature review of adult studies and available youth cohort data.
- Synthesis of current understanding of diagnostic, management, and preventative measures.
- Emphasis on prevalence, clinical presentation, diagnostics, risk factors, and management.
Main Results:
- Neuropathy is a significant complication in youth with diabetes, exacerbated by obesity.
- Understanding is evolving from adult and youth studies regarding presentation and risk factors.
- Current management strategies and recommendations are being established.
Conclusions:
- Addressing the rising incidence of neuropathy in youth with diabetes and obesity requires identifying modifiable risk factors.
- Randomized controlled trials are crucial to evaluate interventions like weight loss and exercise.
- Enhanced awareness and early detection are vital for prevention and management.
Abstract:
Pediatric neuropathy attributed to metabolic dysfunction is a well-known complication in children and youth with type 1 diabetes. Moreover, the rise of obesity and in particular of type 2 diabetes may cause an uptick in pediatric neuropathy incidence. However, despite the anticipated increase in neuropathy incidence, pathogenic insights and strategies to prevent or manage neuropathy in the setting of diabetes and obesity in children and youth remain unknown. Data from adult studies and available youth cohort studies are providing an initial understanding of potential diagnostic, management, and preventative measures in early life. This review discusses the current state of knowledge emanating from these efforts, with particular emphasis on the prevalence, clinical presentation, diagnostic approaches and considerations, and risk factors of neuropathy in type 1 and type 2 diabetes in children and youth. Also highlighted are current management strategies and recommendations for neuropathy in children and youth with diabetes. This knowledge, along with continued and sustained emphasis on identifying and eliminating modifiable risk factors, completing randomized controlled trials to assess effectiveness of strategies like weight loss and exercise, and enhancing awareness to support early detection and prevention, are pertinent to addressing the rising incidence of neuropathy associated with diabetes and obesity in children and youth.
Related Concept Videos
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes: Symptoms, Diagnosis, and Complications
Diabetes Mellitus: Type 2 and Gestational
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

